|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Postinor -- the unique method of emergency contraception developed in |
| PLANNED PARENTHOOD IN EUROPE. 1995 Aug;24(2):23-4. |
| In Hungary, an important form of emergency contraception (EC) is the pill containing 0.75 mg levonorgestrel, which is |
| marketed by Gedeon Richter under the name Postinor in four-pill packages. Women are instructed to take one pill |
| within an hour of any unprotected act of intercourse, up to four pills per month. The nature of the administration |
| requires that women be in possession of the pills before they need them, and, while Postinor is marketed as an EC, |
| the target market is young, unmarried women who experience infrequent intercourse. When it was first offered a |
| decade ago, Postinor gained widespread use in place of contraception. The product was overused and there was a |
| backlash in the medical community. Thus, the manufacturer changed its packaging instructions and removed the |
| original 10-pill package from the market. While the price of the drug is considered prohibitive for use by adolescents, |
| more than three million pills were sold in the past three years in Hungary and more than 60 million pills were sold in |
| over 20 countries. Clinical studies show a failure rate of less than 1% and relatively few side effects (10-20% nausea |
| and 20-40% bleeding) if not more than four pills per month are used. The World Health Organization is currently |
| conducting trials to compare use of Postinor with the Yuzpe method. Results of these trials will be available in |
| 1996. (PubHealth.info Document ID: CONT2T 3006-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Postinor -- the unique method of emergency contraception |
| developed in Hungary.", is(are) Camp S. The source of this article is "PLANNED PARENTHOOD IN EUROPE. 1995 |
| Aug;24(2):23-4.". This article was published in 1995 in English language(s). (PubHealth.info® Document ID: |
| CONT2T 3006-06. All rights reserved with PubHealth.info) PIN: 8006 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |